This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: **Inventor Spotlight: Anthony Shane Ransdell**
Introduction
Anthony Shane Ransdell is an innovative inventor based in Plainfield, Indiana, renowned for his contributions to the pharmaceutical field. With a focus on diabetes treatment, Ransdell has made significant strides that demonstrate the intersection of science and healthcare through his inventive efforts.
Latest Patents
Ransdell holds a noteworthy patent for "Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol." This patent pertains to insulin compositions that include preservatives and a range of agents aimed at enhancing treatment efficacy for diabetes. His invention is pivotal for developing improved therapeutic options for patients managing this chronic condition.
Career Highlights
Ransdell is currently associated with Eli Lilly and Company, a leading global pharmaceutical firm. His role there has enabled him to work on groundbreaking research and product development, contributing not only to his organization's success but also enhancing patient care worldwide. His dedication to innovation is exemplified through the successful patenting of his insulin compositions.
Collaborations
Throughout his career, Ransdell has collaborated with esteemed colleagues, including John Michael Beals and Eric Dwayne Hawkins. These partnerships highlight the collaborative nature of research and development in the pharmaceutical industry, emphasizing how teamwork can lead to monumental advancements in medical treatments.
Conclusion
In summary, Anthony Shane Ransdell has carved a niche for himself as an accomplished inventor in the realm of pharmaceuticals. His commitment to enhancing diabetes treatment through innovative compositions showcases his invaluable contributions to both the scientific community and public health. As he continues to work with Eli Lilly and Company, the potential for further impactful inventions remains promising.